A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity.
Anders StratheDeborah Bade HornMalte Selch LarsenDomenica M RubinoRasmus SørrigMarie Thi Dao TranSean WhartonRune Viig OvergaardPublished in: Diabetes, obesity & metabolism (2023)
An exposure-response model has been established that quantitatively describes the relationship between systemic semaglutide exposure and weight loss and predicts weight-loss trajectories for people with overweight or obesity who are receiving semaglutide doses up to 2.4 mg once weekly.